33
total announcements
POLYMED.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 14 Oct 2026
Market Cap
₹16,208 Cr
P/E (TTM)
51.5
P/E (Forward)
32.7
EPS (TTM)
₹31.06
52W Low
₹1,184.00
52W High
₹2,093.95
Dividend Yield
0.21%
Beta
0.00
Price / Book
5.2
Debt / Equity
11.2
Revenue (TTM)
₹1,997 Cr
Gross Margin
69.49%
Operating Margin
16.91%
Poly Medicure Ltd
Poly Medicure Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and updating the register of members within the specified time frame.
Poly Medicure Ltd
Poly Medicure Ltd has informed the exchange about the closure of trading window in compliance with SEBI regulations, effective from October 1, 2026, till 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026.
Poly Medicure Ltd
Poly Medicure Ltd has announced the schedule of an investors' meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's officials will hold one-on-one meetings with analysts and investors on September 30, 2026, at their plant in Faridabad, Haryana. No unpublished price-sensitive information will be shared during the meeting.
Poly Medicure Ltd
Poly Medicure Ltd has announced a schedule for one-on-one meetings with analysts and investors on September 25, 2026, to discuss unpublished price sensitive information.
Poly Medicure Ltd
Poly Medicure Ltd has announced the schedule of an investor meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's officials will hold one-on-one meetings with analysts/investors on September 8, 2026, at the registered office in New Delhi.
Poly Medicure Ltd
Poly Medicure Ltd has rescheduled its investor/analyst meet from August 20th to August 27th, 2026.
Poly Medicure Ltd
Poly Medicure Ltd has announced a schedule of investor meetings with analysts and investors on August 27th and 31st, 2026.
Poly Medicure Ltd
Poly Medicure Ltd has cancelled its investor meet scheduled for 20 August 2026 due to exigencies.
Poly Medicure Ltd
Poly Medicure Ltd has announced a schedule for one-on-one meetings with analysts/investors on August 20, 2026, to discuss unpublished price sensitive information. The meetings are subject to change due to exigencies.
Poly Medicure Ltd
Poly Medicure Ltd has published a newspaper advertisement regarding its upcoming Annual General Meeting (AGM) to be held on September 05, 2026, through video conferencing.
Poly Medicure Ltd
Poly Medicure Ltd's Q1 FY27 earnings call highlights the company's strategic vision for FY2030, PolyMed 3.0, aiming to double revenue by FY30 through organic and inorganic expansion, leveraging technology, and deepening customer access in international markets. The company reports a 12.3% growth in standalone revenue to INR431 crores, with a 16.2% growth in domestic revenue and 10% growth in international revenue. Gross profit margin improved to 71.5%, and EBITDA margin exceeded the guided range at 28%.
Poly Medicure Ltd
Poly Medicure Ltd has announced its 31st Annual General Meeting (AGM) and Annual Report for the Financial Year ended March 31, 2026, to be held on September 5, 2026.
Poly Medicure Ltd
Poly Medicure Ltd has announced a record date for the purpose of final dividend for the FY 2025-26. The record date is August 29, 2026, and the dividend is 3.50 per equity share on the face value of 5 per share. The dividend will be paid if approved at the upcoming Annual General Meeting on September 5, 2026.
Poly Medicure Ltd
Poly Medicure Ltd has announced a record date and book closure for the purpose of final dividend for FY 2025-26, with a dividend of 3.50 per equity share on the face value of 5 per share.
Poly Medicure Ltd
Poly Medicure Ltd has announced a book closure for the purpose of record date for the final dividend for FY 2025-26, with a record date of August 29, 2026, and a dividend of 3.50 per equity share.
Poly Medicure Ltd
Poly Medicure Ltd has announced the dispatch of a letter to shareholders whose email addresses are not registered with the company or depositories, providing a web link to access the annual report for FY 2025-26 and the notice of the 31st AGM to be held on September 5, 2026. The company also requests shareholders to update their PAN, KYC, and bank details with the RTA.
Poly Medicure Ltd
Poly Medicure Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, as per SEBI regulations.
Poly Medicure Ltd
Poly Medicure Ltd has announced its 31st Annual General Meeting to be held on September 05, 2026, through Video Conferencing or Other Audio-Visual Means. The meeting will consider and adopt the audited standalone financial statements for the year ended March 31, 2026, and other business.
Poly Medicure Ltd
Poly Medicure Ltd has made the audio recording of its earnings conference call for the quarter ended June 30, 2026, available on its website.
Poly Medicure Ltd
Poly Medicure Ltd has submitted a statement of deviation or variation for the quarter ended June 30, 2026, regarding the utilization of funds raised through Qualified Institutions Placement (QIP). The company has reviewed the actual utilization of funds received for an amount aggregating Rs 99,999.98 lakh, which is in line with the objects of the issue. There is no deviation or variation from the objects of the issue in the utilization of proceeds.